Actionable news
All posts from Actionable news
Actionable news in ACAD: ACADIA Pharmaceuticals Inc.,

Acadia Receives FDA Approval Of Nuplazid To Treat Parkinson's Disease Psychosis

On Friday, Acadia Pharmaceuticals (ACAD) announced that it has received FDA approval of Nuplazid for the treatment of Parkinson's Disease Psychosis. The drug received a breakthrough therapy designation by the FDA back in 2014. The Breakthrough Designation allows for faster review time compared to other drugs.

What makes this FDA approval so special is that Nuplazid will be the only drug to be approved by the FDA to treat Parkinson's...